Fujian Cancer Hospital — Fuzhou, Fujian

Public research footprint of Fujian Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

428

Registered studies

271

Active

179

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · Carcinoma, Non-Small-Cell Lung (NSCLC) · mCRPC (Metastatic Castration-resistant Prostate Cancer)

Recently updated registry entries

NCT06380660 — Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors (Active Not Recruiting)
NCT07564466 — A Study of SKB571 in Participants With Gastrointestinal Tumors (Recruiting)
NCT04958239 — A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fujian Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.